During the past decade, VISSUM Madrid Santa Hortensia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "VISSUM Madrid Santa Hortensia" are "Geographic Atrophy" (2 trials). Many other conditions were trialed in "VISSUM Madrid Santa Hortensia" in a lesser frequency.

Most popular intervention types in "VISSUM Madrid Santa Hortensia" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials) and "Sham Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "VISSUM Madrid Santa Hortensia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "VISSUM Madrid Santa Hortensia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in VISSUM Madrid Santa Hortensia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in VISSUM Madrid Santa Hortensia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".